Viatris Inc. (VTRS) vs Zoetis Inc. (ZTS)
- Viatris Inc. VTRS 18.66 +2.41%
- Zoetis Inc. ZTS 79.20 +0.99%
Viatris Inc. and Zoetis Inc. are both Drug Manufacturers Specialty & Generic companies. Zoetis Inc. is the larger, with a market value of $32.4B against $20.9B — 1.5× the size. Viatris Inc. has negative trailing earnings, so its P/E is not meaningful; Zoetis Inc. trades at 13.0×. Viatris Inc. grew revenue faster over the last twelve months: 4.40% against 1.58%. Zoetis Inc. has the higher net margin (27.7% vs −2.79%) and the higher return on invested capital (19.6% vs −0.20%). Both pay a dividend; Zoetis Inc. yields more (2.64% vs 2.57%). Across the 22 metrics below, Zoetis Inc. leads on 15 and Viatris Inc. on 7.
Valuation
Profitability
| Metric | VTRS | ZTS | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 34.83% | 71.67% | 53.94% |
| Operating margin | (0.59%) | 37.13% | 0.00% |
| Net margin | (2.79%) | 27.69% | 0.00% |
| Free cash flow margin | 12.83% | 24.43% | 0.00% |
| Return on equity | (2.75%) | 64.91% | (0.40%) |
| Return on assets | (1.12%) | 17.84% | (3.32%) |
| Return on invested capital | (0.20%) | 19.60% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack